ArticleFrontiers in oncology2023

Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21.

Claudia Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.